MOUNTAINSIDE, N.J., Dec. 17 /PRNewswire-FirstCall/ -- National Stem Cell Holding, Inc. (Other OTC: NHGI) today announced that its company information, financial information, quotations and press releases are posted on the OTCIQ, a service of the Pink Sheets.
OTCIQ is a secure, web-based portal that provides issuers access to
innovative products and services to facilitate communication with the
marketplace, promote transparency, mitigate risk, gather market
intelligence, and inspire better corporate governance. OTCIQ subscribers
are assigned secure, personalized user credentials to manage the
publication and dissemination of all of their corporate information and
The OTCIQ service includes:
secure user login
Pink Sheets News Service -
Real-time Level II quotes
Michael Cohen, President, stated: "We have taken the early steps in good faith to report our up-to-date information on the OTCIQ. I am also pleased to announce that we have retained a CFO and a new general counsel that has propelled the company in a short period of time closer to filing SEC documentation to become a fully reporting company."
National Stem Cell Holding, Inc. is a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives. The Company is developing a pipeline of proprietary stem cell therapeutics with particular focus on diabetes. In addition to its work with stem cell therapeutics, the Company is also working to leverage its commercial infrastructure and product development capabilities of its wholly-owned subsidiary The Sperm Bank of NY. The Company's investigational products are focused on the improvement of the quality of life for patients and their families. The Company is headquartered in Mountainside, NJ. For more information, please visit http://www.nationalstemcell.com and http://www.pinksheets.com .
"Safe Harbor Statement" Under The Private Securities Litigation Reform Act of 1995: The statements in the press release that relate to the company's expectations with regard to the future impact on the company's results from new products in development are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The results anticipated by any or all of these forward-looking statements may not occur. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect
events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company's plans or expectations.
|SOURCE National Stem Cell Holding, Inc.|
Copyright©2007 PR Newswire.
All rights reserved